Patients at risk of onychomycosis - Risk factor identification and active prevention

Journal of the European Academy of Dermatology and Venereology

Volumn 19, Issue SUPPL. 1, 2005, Pages 13-16

  Tosti, A ^a   Hay, R ^b   Arenas Guzman R ^c  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^c NONE   (Mexico)

Author keywords

Onychomycosis; Prevention; Recurrence; Risk factors

Indexed keywords

ANTIFUNGAL AGENT;

AGE; ARTERY DISEASE; CONFERENCE PAPER; CONSENSUS; DERMATOPHYTE; DIABETES MELLITUS; DIABETIC FOOT; FOLLOW UP; GENETIC SCREENING; HEREDITY; HIGH RISK POPULATION; HUMAN; IMMUNE DEFICIENCY; INFECTION RISK; NAIL INFECTION; ONYCHOMYCOSIS; PATIENT COMPLIANCE; PATIENT EDUCATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; PSORIASIS; REINFECTION; SPORT; TINEA PEDIS; TREATMENT FAILURE; TRICHOPHYTON RUBRUM;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ANTIBIOTICS, ANTIFUNGAL; ANTIFUNGAL AGENTS; CHILD; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYGIENE; INCIDENCE; ITALY; MALE; MIDDLE AGED; ONYCHOMYCOSIS; PRIMARY PREVENTION; RECURRENCE; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION;

EID: 28444476968     PISSN: 09269959     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2005.01282.x     Document Type: Conference Paper

References (21)

1. Elewksi BW, Charif MA. Prevalence of onychomycosis in patients attending a dermatology clinic in northeastern Ohio for other conditions. Arch Dermatol 1997; 133: 1172-1173.
2. Faergemann J, Baran R. Epidemiology, clinical presentation and diagnosis of onychomycosis. Br J Dermatol 2003; 149: 1-4.
3. Heikkilä H, Stubb S. The prevalence of onychomycosis in Finland. Br J Dermatol 1995; 133: 699-703.
4. Sigurgeirsson B, Steingrimsson O. Risk factors associated with onychomycosis. J Eur Acad Dermatol Venereal 2004; 18: 48-51.
5. Zaias N, Tosti A, Rebell G et al. Autosomal dominant pattern of distal subungual onychomycosis caused by Trichophyton rubrum. J Am Acad Dermatol 1996; 34: 302-304.
6. Faergemann J, Correia O, Nowicki R, Ro BI. Genetic predisposition - understanding underlying mechanisms of onychomycosis. J Eur Acad Dermatol Venereal 2005; 19: 17-19.
7. Gupta AK, Taborda P, Taborda V et al. Epidemiology and prevalence of onychomycosis in HIV-positive individuals. Int J Dermatol 2000; 39: 746-753.
8. Cribier B, Mena ML, Rey D et al. Nail changes in patients infected with human immunodeficiency virus. A prospective controlled study. Arch Dermatol 1998; 134: 1216-1220.
9. Gianni C, Cerri A, Capsoni F et al. Recurrent proximal white subungual onychomycosis associated with a defect of the polymorphonuclear chemotaxis. Eur J Dermatol 1999; 9: 390-392.
10. Gupta AK, Konnikov N, MacDonald P et al. Prevalence and epidemiology of toenail onychomycosis in diabetic subjects: a multicentre survey. Br J Dermatol 1998; 139: 665-671.
11. Dogra S, Kumar B, Bhansali A, Chakrabarty A. Epidemiology of onychomycosis in patients with diabetes mellitus in India. Int J Dermatol 2002; 41: 647-651.
12. Gupta AK, Lynde CW, Jain HC et al. A higher prevalence of onychomycosis in psoriatics compared with non-psoriatics: a multicentre study. Br J Dermatol 1997; 136: 786-789.
13. Larsen GK, Haedersdal M, Svejgaard EL. The prevalence of onychomycosis in patients with psoriasis and other skin diseases. Acta Derm Venereal 2003; 83: 206-209.
14. Gupta AK, Gupta MA, Summerbell RC et al. The epidemiology of onychomycosis: possible role of smoking and peripheral arterial disease. J Eur Acad Dermatol Venereal 2000; 14: 466-469.
15. Saez de Ocariz MM, Arenas R, Ranero-Juarez GA, Farrera-Esponda F, Monroy-Ramos E. Frequency of toenail onychomycosis in patients with cutaneous manifestations of chronic venous insufficiency. Int J Dermatol 2001; 40: 18-25.
16. Caputo R, De Boulle K, Del Rosso J, Nowicki R. Prevalence of superficial fungal infections among sports-active individuals: results from the Achilles survey, a review of the literature. J Eur Acad Dermatol Venereal 2001; 15: 312-316.
17. Gudnadottir G, Hilmarsdottir I, Sigurgeirsson B. Onychomycosis in Icelandic swimmers. Acta Derm Venereal 1999; 79: 376-377.
18. Scher RK, Baran R. Onychomycosis in clinical practice: factors contributing to recurrence. Br J Dermatol 2003; 149: 5-9.
19. Tosti A, Piraccini BM, Lorenzi S. Onychomycosis caused by nondermatophytic molds: clinical features and response to treatment of 59 cases. J Am Acad Dermatol 2000; 42: 217-224.
20. Gupta AK, Lynch LE. Onychomycosis: review of recurrence rates, poor prognostic factors, and strategies to prevent disease recurrence. Cutis 2004; 74: 10-15.
21. Tosti A, Piraccini BM, Ghetti E, Colombo MD. Topical steroids versus systemic antifungals in the treatment of chronic paronychia: an open, randomized double-blind and double dummy study. J Am Acad Dermatol 2002; 47: 73-76.